Nitroglycerin and long-acting nitrates in clinical practice

The American Journal of Medicine
J Abrams

Abstract

Nitrates are potent relaxers of vascular smooth muscle and act by dilating veins, arteries, and arterioles (especially at high doses). Their clinical effects have been considered to be dominantly related to peripheral actions: systemic venodilatation and a decrease in systemic vascular resistance, reducing the preload and afterload of the heart. Considerable experimental work confirms potent salutary effects on the coronary circulation. These drugs are readily absorbed across mucosal surfaces; they are available in multiple formulations, including sublingual, buccal, oral, and topical delivery systems. Nitrate administration should begin with low doses and increased to doses that are often higher than previously recommended until a specific clinical end point or limiting side effects occur. Organic nitrate esters are effective in the treatment of stable angina pectoris, unstable angina, coronary vasospastic syndromes, and in vasodilator therapy in severe congestive heart failure. The pathophysiology of these syndromes is reviewed with respect to the clinical actions of nitrates on the central and peripheral circulations. The side effects of nitrates include headache, dizziness, and nausea. Nitrate tolerance, a controversial sub...Continue Reading

References

Aug 4, 1978·JAMA : the Journal of the American Medical Association·J A FranciosaJ N Cohn
Feb 1, 1978·The American Journal of Medicine·J Abrams
Mar 1, 1975·Circulation·D O WilliamsD T Mason
Nov 1, 1973·The Journal of Clinical Investigation·M V CohenE S Kirk
Aug 1, 1971·Annals of Internal Medicine
Sep 1, 1981·Journal of Pharmaceutical Sciences·E F McNiffH L Fung
Jul 1, 1982·Progress in Cardiovascular Diseases·H S RibnerJ Askenazi
Oct 1, 1982·Circulation·M McGregor
Jun 1, 1980·The American Journal of Nursing·M S Hansen, S L Woods
Oct 1, 1980·The American Journal of Cardiology·P W ArmstrongG S Marks
Nov 1, 1980·European Journal of Clinical Pharmacology·P R ImhofJ Hodler
Mar 1, 1981·The Journal of Clinical Investigation·R I LevinK Tack-Goldman
Oct 2, 1981·JAMA : the Journal of the American Medical Association·J Abrams
Nov 1, 1982·Annals of Internal Medicine·N Reichek, M S Sutton

❮ Previous
Next ❯

Citations

Mar 1, 1987·Current Problems in Cardiology·A C Cuetter, V J Ferrans
Oct 19, 2000·Cephalalgia : an International Journal of Headache·I ChristiansenJ Olesen
Oct 19, 2000·Cephalalgia : an International Journal of Headache·I ChristiansenJ Olesen
Jun 22, 1984·The American Journal of Medicine·J Abrams
Jun 22, 1984·The American Journal of Medicine·C J PepineJ S Gelman
Nov 3, 2011·Archives of Cardiovascular Diseases·Jean-Louis GayetAlain Cohen-Solal
Dec 27, 1985·The American Journal of Cardiology·W H Frishman
Mar 1, 1988·British Journal of Urology·D E ParkinR P Symonds
Jun 17, 2003·Cephalalgia : an International Journal of Headache·M Empl, G Giovannoni
Jan 1, 1987·Vox Sanguinis·H Vinazzer
Oct 21, 2009·Echocardiography·Anil GeorgeAssad Movahed
Jan 1, 1986·Acta Pharmacologica Et Toxicologica·R Nordlander
Jan 1, 1985·Acta Medica Scandinavica. Supplementum·K Luomanmäki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.